Accelerate your R&D pipeline with world‑class Selective TNF‑α binder and Selective neuromedin B ligand from Global Technology Co., Ltd. Designed for corporate purchasing managers, technical directors, and operations leaders who demand consistent potency, regulatory‑ready documentation, and on‑time delivery.
Get Free Quote in 24 h1. High‑Cost API Procurement
Many U.S. biotech firms still rely on legacy suppliers whose price lists have risen 15‑30 % year‑over‑year due to fragmented supply chains. The result? budget overruns that force project postponement.
2. Inconsistent Purity & Activity
When the assay variability of a “Selective TNF‑α binder” exceeds ±10 %, downstream cell‑based studies become unreliable, leading to repeat experiments and delayed IND filing.
3. Lengthy Lead Times & Shipping Delays
Average transit from Asian manufacturers to the U.S. now averages **45 days**, with customs holds adding another 7‑10 days. For fast‑moving therapeutic programs, this latency translates directly into lost market opportunity.
4. Regulatory Uncertainty
Without a GMP‑certified production line and full DMF (Drug Master File) support, compliance teams spend extra weeks preparing FDA submissions, increasing total project cost by up to 22 %.
Discover how Global Technology eliminates these pain points →
| Parameter | Selective TNF‑α Binder | Selective Neuromedin B Ligand |
|---|---|---|
| Purity (HPLC) | ≥99.8 % | ≥99.7 % |
| Molecular Weight | 12,342 Da | 8,765 Da |
| EC50 (TNF‑α) | 0.45 nM | — |
| Kd (Neuromedin B) | — | 0.12 nM |
| Formulation | Lyophilized powder, 10 mg/vial | Lyophilized powder, 5 mg/vial |
| Stability (25 °C/60 % RH) | 24 months | 18 months |
| Certificate of Analysis (CoA) | Provided with every batch | |
1. In‑vitro Cytokine Inhibition Screening – A leading US biotech used our Selective TNF‑α binder to replace a legacy peptide in a high‑throughput assay. Result: 35 % reduction in assay variability and a 2‑week acceleration of lead‑identification.
2. Neuromedin B Receptor Pharmacology – A pharmaceutical company developing a novel obesity therapeutic integrated our Neuromedin B ligand into their receptor‑binding studies. The ligand’s Kd = 0.12 nM enabled a 3‑fold increase in signal‑to‑noise ratio, cutting the required cell‑culture volume by 40 %.
3. GMP‑Grade Clinical Supply – For a Phase I trial, Global Technology delivered 2 kg of GMP‑certified TNF‑α binder within 28 days, meeting FDA’s IND timeline and saving the sponsor an estimated $120,000 in expedited shipping fees.
CAS-117505-80-3-5-Bromo-2-chloropyrimidine CAS-5102-83-0-1,2-Bis(2-amino-5-chlorobenzophenone) Acetomycin Neuropeptide-Y-receptor-pharmacology-research-tool-ligand
The MOQ is **10 g** for research‑grade material. For GMP‑grade, we start at **500 g** and can scale to multi‑kilogram batches.
Yes. Our OEM/ODM team can synthesize custom analogues with **≤0.5 % impurity**. Turn‑around time for small‑scale custom work is **10‑14 days**.
Each batch undergoes a full suite of analytical tests (HPLC, LC‑MS, NMR, bio‑assay) and receives a detailed Certificate of Analysis. Our GMP‑certified facility follows a **strict SOP hierarchy** to eliminate variability.
We accept **T/T (30 % upfront, 70 % L/C)**, **PayPal**, and **U.S. corporate credit cards**. For long‑term partners, net‑30 or net‑60 terms can be arranged after credit approval.
Yes. We provide **DDP (Delivered Duty Paid)** service to any U.S. address, including FDA‑approved cold‑chain facilities. Tracking is available within **24 hours** of dispatch.
Our technical service team provides **24 h email support**, a **dedicated account manager**, and **on‑site troubleshooting** (via video conference) for any stability or assay‑performance questions.
Absolutely. We offer **free 100 mg samples** (subject to verification) with a **money‑back guarantee** if the material does not meet the specifications outlined in the CoA.
Limited‑time offer: **Free 100 mg sample** + **20 % discount on the first commercial batch** (valid until 30 June 2026). Stock is limited; our high‑speed production line fills orders on a first‑come, first‑served basis.
Sarah Patel, Procurement Lead – AstraZeneca – “The **speed** of delivery and **transparent documentation** allowed us to close our Q‑submissions two weeks ahead of schedule.”
James Liu, Technical Director – Biogen – “Purity above 99.8 % gave us confidence in downstream process development – we observed a **15 % increase** in overall yield.”
Olivia Martinez, R&D Manager – Vertex – “Their **free sample** program is a game‑changer. No hidden fees, no surprises.”
Global Technology Co., Ltd – No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com | Contact Page
© 2026 Global Technology Co., Ltd. All rights reserved. Privacy Policy
Trusted by Industry Leaders Worldwide
What Our Clients Say
“Switching to Global Technology’s TNF‑α binder cut our assay CV from 12 % to **4 %**. The **speedy delivery** let us file our IND **three weeks early**.”
“We saved **$45,000** on shipping by using their DDP service. Quality was **consistent** across three consecutive batches.”
“The neuromedin B ligand’s **sub‑nanomolar affinity** gave us a clear pharmacodynamic signal, shortening our lead‑optimization phase by **2 months**.”
Compliance & Certifications
CE, FDA, ISO 9001, GMP, DMF, RoHS, FCC, CB, GS, VDE, SAA, HACCP/GMP, IPPC – All certificates are downloadable from our portal and included with every shipment.